NANECH
Research NANECH on Bullrun: market cap SEK 6.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNANECH
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 6.11M
- Financial periodQ1 2026
- RevenueSEK 0
- Net income-SEK 5.22M
- Free cash flow-SEK 4.67M
Valuation Snapshot
latest market cap is SEK 6.11M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.06 | SEK 2.13M | SEK 0 | SEK 14.73M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-13 | SEK 6.11M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About NANECH
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.
Related stock research
Other Healthcare stocks
Abera Bioscience AB (ABERA.ST)
Ascelia Pharma AB (publ) (ACE)
AcouSort AB (ACOU)
Active Biotech AB (ACTI)
AlzeCure Pharma (ALZCUR)
Alzinova (ALZ.ST)
Annexin Pharmaceuticals (ANNX.ST)
Alligator Bioscience AB (ATORX)
BioInvent International (BINV.ST)
BioArctic AB (publ) (BIOA-B)
Biosergen AS (BIOSGN)
Biovica International AB (publ) (BIOVIC-B)
Frequently asked questions
What is NANECH's market cap?
NANECH's market capitalization is SEK 6.11M.
What does NANECH do?
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.